Research-use boundary

This article is educational and limited to non-clinical research context, documentation practices, and terminology. It does not provide preparation, administration, dosing, treatment, diagnostic, cosmetic, or consumer-use guidance, and nothing here indicates that any material is suitable for human or animal use.

Leucine and isoleucine have exactly the same mass

Not similar, not close, not separable at higher resolution — identical. As residues in a chain both are C6H11NO, and calculated from the atomic masses published by the National Institute of Standards and Technology both come to 113.08406 daltons. The difference between them is where a methyl group sits on a four-carbon side chain, and connectivity has no mass. No mass spectrometer at any resolving power can report a number that distinguishes them, because there is no difference in the number to find. Writing in Analytical Chemistry in 2016, a group at Biogen opened by stating the position plainly: leucine and isoleucine have been generally considered indistinguishable by mass spectrometry because their molecular masses are exactly the same. The method they published to get around it needed high-energy collisional dissociation across multiple stages combined with electron-transfer dissociation at MS3 on an Orbitrap Fusion, and they validated it for peptides carrying up to five such residues and masses up to about 3,000 daltons. That is a dedicated research programme on a high-end instrument. It is not what happens when a certificate of analysis records that the observed mass agreed with the theoretical one.

What a mass measurement is actually evidence of

A mass spectrometer measures mass-to-charge ratio, from which the mass of the intact molecule is derived. Comparing that observed mass against the mass calculated from the intended sequence tests one specific proposition: that the sample has the elemental composition the sequence predicts. That is a real and useful test. A deletion sequence missing a residue, a truncation, most single substitutions, an oxidation adding sixteen daltons, a peptide that is simply a different compound — all of these move the mass and are caught. What the comparison cannot test is the order and connectivity of the residues, because composition is a sum and a sum discards arrangement. The distinction is not a technicality invented for this article; it is how the international guidance is organised.

ICH Q6B files mass under physical properties, not structure

ICH Q6B is the harmonised guideline on specifications for biotechnological and biological products, and its characterisation appendix is split. Section 6.1.1 covers structural characterisation and confirmation, and lists amino acid sequence, amino acid composition, terminal amino acid sequencing, and peptide mapping. Molecular weight does not appear there. It appears in section 6.1.2, under physicochemical properties, alongside isoform pattern and extinction coefficient. On identity, the guideline states that the identity test should be highly specific for the drug substance and based on unique aspects of its molecular structure or other specific properties, and that more than one test may be necessary to establish identity. It also observes that absolute purity is difficult to determine and that results are method-dependent. Read together, the structure of that document is an argument: a mass is a property of the material, and confirming a structure is a separate activity that takes a different set of methods.

The differences that cost exactly zero daltons

  • Leucine and isoleucine, in either direction. A peptide with n leucine-or-isoleucine positions has 2 to the power of n sequences that share one mass; six such positions give sixty-four.
  • A D-amino acid in place of an L-amino acid. Racemisation during synthesis produces an epimer with the same formula and the same mass. A study of Fmoc solid-phase synthesis of a model 20mer found cysteine, histidine and aspartic acid susceptible, with histidine and cysteine racemisation reduced by lowering the coupling temperature from 80 to 50 degrees Celsius.
  • Aspartic acid rearranged to isoaspartic acid, which moves the backbone through the side chain. The 2011 Analytical Chemistry work on differentiating the two describes the task as challenging precisely because their molecular masses are identical.
  • Disulfide bonds connecting the same cysteines in a different pattern. A 2017 study distinguishing regio-isomers of two-disulfide peptides had to separate side-by-side, overlapped and looped-within-a-loop arrangements — three distinct molecules, one formula.
  • Any reordering of the same residues. A scrambled sequence and the intended sequence are composed of the same parts, so they weigh the same.

Two glycines weigh exactly what one asparagine weighs

Beyond isomers of the same sequence there is a second class of collision, where different residues sum to the same formula. Two glycine residues are C4H6N2O2 and total 114.04293 daltons. One asparagine residue is C4H6N2O2 and is 114.04293 daltons. This is not a rounding artefact or a near-miss at four decimal places; the elemental compositions are the same, so the masses are equal exactly and no instrument will ever separate them. The same holds for glycine plus alanine against glutamine: both are C5H8N2O2 at 128.05858 daltons, in either order. A synthesis error that swapped one residue for two others of matching composition would leave the intact mass untouched. These cases are rarer in practice than a plain deletion, which is the point — the errors a mass check catches are the common ones, and the errors it misses are the ones that survive to the certificate.

Where resolving power does decide the answer

Some differences are small rather than absent, and there the instrument matters. Glutamine and lysine both round to 128 daltons but differ by 0.03639 daltons, which is a genuine separation: distinguishing them on a 1,000-dalton peptide needs a resolving power near 27,000 by the mass-divided-by-mass-difference definition, and near 82,000 on a 3,000-dalton peptide. Deamidation is the harder case. Converting asparagine to aspartic acid, or glutamine to glutamic acid, adds 0.98402 daltons. The spacing between a carbon-13 isotope peak and its carbon-12 parent is 1.00335 daltons. The two differ by 0.01934 daltons, so a deamidated molecule appears just below the first isotope peak of the unmodified one, hiding inside an isotope envelope that is expected to be there. Separating those two on a 1,000-dalton peptide takes a resolving power near 52,000, and near 155,000 at 3,000 daltons. Because the mass-to-charge gap and the mass-to-charge value both scale with charge state, that requirement is set by the mass of the peptide rather than by which charge state is observed.

Monoisotopic against average, and comparing like with like

A related error needs no isomer at all. The monoisotopic mass is calculated from the lightest stable isotope of each element; the average mass is calculated from the natural abundance-weighted atomic weights. For a small peptide the two are close, and they diverge steadily as the chain lengthens: for typical peptide elemental compositions the gap is under a dalton at 1,000 daltons, about 1.2 daltons at 2,000, and about 2.4 daltons at 4,000. A certificate that reports one and a calculation that predicts the other can produce an apparent discrepancy of a few daltons where nothing is wrong, or conceal a real one-dalton shift such as deamidation inside the mismatch. This is why an observed-versus-theoretical line is only interpretable when the record states which mass convention was used, and what tolerance was applied.

What does confirm a sequence

Sequence confirmation means fragmenting the chain and reading the resulting ladder, which is what peptide mapping does: the molecule is cleaved into defined pieces with an enzyme or a chemical reagent, the pieces are separated chromatographically, and the fragments are identified by mass spectrometry, terminal sequencing or composition analysis. ICH Q6B describes peptide mapping under an appropriately validated procedure as a method frequently used to confirm the structure of the desired product for lot release purposes. Fragmentation restores the information that an intact mass discards, because a ladder of fragment masses reports where each residue sits rather than only that it is present somewhere. It does not restore all of it. A fragment ladder still cannot call leucine against isoleucine, and it still cannot call D against L, without the specialised dissociation chemistry described above.

Some of these calls are comparisons, not readings

The aspartate-isoaspartate case shows how far this goes. A 2000 study in Protein Science examined fifteen matched pairs of synthetic peptides differing only in that substitution and found consistent signatures under low-energy collision-induced dissociation: the intensity ratio of complementary b and y ions at the affected bond decreased, and the abundance of the aspartate immonium ion at mass-to-charge 88 decreased. The authors were explicit about what that buys. The ratios vary considerably with sequence, and are reproducible only on the same instrument under identical settings, so the method identifies one form or the other once reference spectra have been documented for a pair of synthetic standards. That is a comparison against a known material, not a measurement read off an unknown. It is a good illustration of a general rule in this area: the harder the isomer, the more the answer depends on having the right reference standard rather than on having a better instrument.

How to read an identity line on a certificate

  • Ask which mass was reported and which was calculated — monoisotopic or average. Without that, an observed-versus-theoretical comparison cannot be checked.
  • Ask what the acceptance tolerance was. A tolerance wider than one dalton cannot exclude deamidation, and a tolerance wider than about 0.04 daltons cannot exclude a glutamine-lysine confusion.
  • Ask whether any fragmentation was performed. An intact-mass measurement and a peptide map are different records, and only the second addresses residue order.
  • Treat matching mass as excluding a class of errors rather than as confirming a sequence. It rules out deletions, truncations, most substitutions and oxidation; it does not rule out any isomer of the intended molecule.
  • Remember that absence of a test is information. A certificate that reports mass agreement and nothing else has answered the composition question and left the structure question open.

Why this is worth a reviewer's attention

The point is not that mass spectrometry is unreliable — it is among the most precise measurements a laboratory can make, and an observed mass matching theory to four decimal places is strong evidence about composition. The point is that precision and specificity are different properties, and a measurement can be extraordinarily precise about a quantity that does not uniquely identify the molecule. Every isomer listed above is a real synthesis or degradation product, and every one of them passes an intact-mass check by construction. A reviewer who reads mass conformance as sequence confirmation has quietly upgraded the evidence, and the errors that survive that upgrade are exactly the ones that no amount of instrument time will surface afterwards.